PHILADELPHIA, Jan. 15, 2015 /PRNewswire/ -- Olfactory Biosciences Corp. (OLFC) is pleased to announce 9 revolutionary New Age Medicines for 2015. The new products use natural ingredients, advanced Olfaction and chemoreception. Applying topical medicine is just rubbing a small amount of the medicine balm to the end of your nostrils.
Olfactory receptors are nerves and neurotransmitters and act by attaching to the company's natural ingredients, dependent on what the issue is to be solved. No aromatherapy or any known medical therapy or science is used. Olfactory Biosciences uses a new innovative delivery system, the company's science and that of the NOBEL Prize winners in Medicine 2004.
The lineup of the new advanced innovative topical medicines are below and are presented at www.noxoinfo.com
Provides hours of relief from cravings and overeating.
Relief from sensory issues and challenges
that have the potential to trigger coping responses.
Less stress and stress
related symptoms in your life.
Less anxiety, from a natural
solution. Gain more calm and control.
A great, natural night's sleep
6. Nootravate ™
A great, natural way to improve your memory
Avoid the dangerous trend of taking
chemical drugs and excel with natural
help and memory enhancement.
8. Emoodal ™
Makes people feel in the best Mood
in a calm-energy state.
9. NOXO Odor Defense Pro™
A great, natural way to relieve the distress
and symptoms associated with noxious odors.
For more information go to http://www.noxoinfo.com.
Ingredients: See http://www.noxoinfo.com
Each medicine Balm Tin is 3 oz. (about 100 doses or applications)
About Olfactory Biosciences Corp.
Olfactory Biosciences Corp. develops products targeting olfactory receptors in the nose for the desired effect. These topical medicine products can modify behavior or provide relief to common behavior challenges such as anxiety, sensory issues or help with weight control. http://www.noxoinfo.com/
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
SOURCE Olfactory Biosciences Corp.